MS RESEARCH AUSTRALIA BRAIN BANK NEWS
Secondary progressive MS, a form of MS that can follow on from relapsing remitting MS, currently has no […]
The PBAC has recommended the PBS criteria for two existing MS medications, Gilenya and Tysabri, be broadened which would allow reimbursement for young people with MS.
Up to 65% of people with MS report difficulties with thinking and memory, but many cognitive tests cause […]
An Australian research team supported by MS Research Australia has developed a non-invasive method to boost the production of myelin in the brain.
Watch Associate Professor Justin Rubio explain how he is looking at changes in DNA in brain cells to discover more about progressive MS.